Tempus
Tempus's full profile: funding, valuation, competitors, and the people behind the company.
Awaira Score
Out of 100
HQ
United States
Founded
2015
Raised
$1.05B
Stage
Public
Team
2500
About Tempus
Tempus is an AI-driven oncology and precision medicine company founded in 2015 that utilizes machine learning and data analysis to improve cancer treatment outcomes. The platform aggregates and analyzes vast datasets including clinical data, imaging, molecular information, and outcomes to identify personalized treatment strategies for cancer patients. Tempus's core technology uses artificial…
Key Facts
- Tempus is valued at $8.1B as of March 2026.
- Tempus has raised a total of $1.05B in disclosed funding across 5 funding rounds.
- Tempus was founded in 2015 by Eric Lefkofsky and is headquartered in United States.
- Tempus employs approximately 2500 people.
- Tempus operates in the AI Healthcare category and is currently at the Public stage.
- Tempus has an Awaira Score of 84/100, ranking it among the highly notable AI companies on Awaira.
- Tempus's most recent funding round was a IPO closed in July 2021.
Source: Awaira · Updated Mar 23, 2026
Valuation
$8.1B
Post-money
Total Raised
$1.05B
All rounds
Awaira Score
84/100
Founded
2015
2500 employees
Strengths & Risks
Strengths
Raised over $1.05B — one of the best-funded AI companies
Unicorn status with $8.1B valuation
Elite Awaira Score of 84/100
Analysis based on publicly available data. Not investment advice.
Funding Velocity
5
Total Rounds
$90M
Avg Round Size
5.6yr
Funding Span
Tempus raised 5 rounds over 5.6 years, averaging $90M per round — a pace of roughly one round every 13 months.
Awaira estimate based on public data. Not financial advice.
How does Tempus stack up against competitors?
Competitor Comparison
| Metric | ★Tempus | Butterfly Network | Alan | Abridge |
|---|---|---|---|---|
| Awaira Score | 84/100 | 85/100 | 83/100 | 76/100 |
| Total Raised | $1.05B | $370M | $750M | $800M |
| Valuation | $8.1B | $957M | $5.83B | $5.3B |
| Stage | Public | Public | Series D | Series E |
| Founded | 2015 | 2011 | 2016 | 2018 |
| Employees | 2500 | 500-1000 | 500-1000 | 120 |
| Country | 🇺🇸 | 🇺🇸 | 🇫🇷 | 🇺🇸 |
Funding Rounds
InactiveUndisclosed
Jul 2021
$175M
Jan 2021
$110M
Jan 2019
$45M
Jan 2017
$30M
Jan 2016
Tempus Latest News
GE Ventures Portfolio Company Tempus Sees AI-Driven Growth in Healthcare
Tempus AI Goes Public in $6.1 Billion IPO
Tempus Launches Next-Generation AI Capabilities for Enterprise Customers
Tempus Partners with Pathos AI to Expand AI-Driven Cancer Diagnostics
Open Positions at Tempus
View all jobs →Founded Same Year (2015)
Similar by Funding Stage (Public)
More from United States
🇺🇸 View all AI companies in United States →Alternatives
View all alternatives to Tempus →If you're looking at Tempus, also check out
View all AI Healthcare →People Also Viewed
Frequently Asked Questions
What is Tempus's valuation?▾
Who invested in Tempus?▾
When did Tempus last raise funding?▾
How many employees does Tempus have?▾
What does Tempus do?▾
Who founded Tempus?▾
Is Tempus profitable?▾
Where is Tempus headquartered?▾
Compare Tempus
See how Tempus stacks up against competitors in valuation, funding, team size, and Awaira Score.